Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian national expert group

W. Kocha, J. Maroun, H. Kennecke, C. Law, P. Metrakos, J. F. Ouellet, R. Reid, C. Roswell, A. Shah, S. Singh, S. Van Uum, R. Wong

Abstract


Well-differentiated neuroendocrine tumours (NETs-previously called "carcinoid tumours") are relatively rare tumours originating from the diffuse neuroendocrine system; they are found most often in the bronchial or gastrointestinal systems. In Canada, gastroenterohepatic NETs represent \ less than 0.25% of oncology cases. Because of the relative rarity of these tumours, diagnostic and therapeutic approaches vary and are often based on individual physician experience. A number of European and North American groups have developed consensus guidelines for the diagnosis and management of well-differentiated gastroenterohepatic nets, and in 2006, Canadian consensus guidelines were published by a Canadian expert group. The updated and expanded current Canadian guidelines are based on a consensus meeting held in Paris, France, in 2008 nd are based on the most current literature.


Full Text:

PDF


DOI: http://dx.doi.org/10.3747/co.v17i3.484






Copyright © 2019 Multimed Inc.
ISSN: 1198-0052 (Print) ISSN: 1718-7729 (Online)